Home/Publication/LAV, Boyu & HongShan Re-up in Gene Therapy Play
LAV, Boyu & HongShan Re-up in Gene Therapy Play 

09 Aug 2024

US$ 19.00

Lilly Asia Ventures, Boyu Capital, Zoo Capital, HongShan and New Alliance Capital have made a follow-on investment ......

Price / article: US$19.00
OR existing subscriber
Related Publications

Asian Infrastructure Investment Bank (AIIB), a multilateral development bank focusing on sustainable economic ......

Boyu Capital (Boyu) is to take a 60% equity interest in a joint venture with Starbucks Corp (Starbucks) to manage ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.